reiterateINTRfinnhub
UBS Reiterates Buy Rating on Inter & Co, Inc. (INTR)
UBS reiterated its Buy rating on Inter & Co, Inc. (NASDAQ:INTR) on October 20, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
UBS reiterated its Buy rating on Inter & Co, Inc. (NASDAQ:INTR) on October 20, 2026.
Read moreBaird reiterated its Outperform rating on Zions Bancorporation, National Association (NASDAQ:ZIONO) on October 20, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Zions Bancorporation, National Association (NASDAQ:ZIONO) on October 20, 2026.
Read moreTD Cowen reiterated its Hold rating on Zions Bancorporation, National Association (NASDAQ:ZIONO) on October 20, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Liberty Global plc (NASDAQ:LBTYB) on October 20, 2026.
Read moreUBS reiterated its Buy rating on Chord Energy Corporation (NASDAQ:CHRD) on October 20, 2026.
Read moreBarclays reiterated its Overweight rating on Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) on October 20, 2026.
Read moreEvercore ISI Group reiterated its In-Line rating on BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) on October 20, 2026.
Read moreRBC Capital reiterated its Outperform rating on Fifth Third Bancorp (NASDAQ:FITB) on October 20, 2026.
Read moreSusquehanna reiterated its Neutral rating on Live Nation Entertainment, Inc. (NYSE:LYV) on October 20, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Adagene Inc.
Read moreHC Wainwright & Co. reiterated its Buy rating on Crescent Biopharma, Inc.
Read moreStifel reiterated its Buy rating on Cooper-Standard Holdings Inc. (NYSE:CPS) on October 19, 2026.
Read moreTD Cowen reiterated its Buy rating on CEVA, Inc. (NASDAQ:CEVA) on October 19, 2026.
Read moreBTIG reiterated its Buy rating on Verastem, Inc. (NASDAQ:VSTM) on October 19, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on CareDx, Inc (NASDAQ:CDNA) on October 19, 2026.
Read moreCanaccord Genuity analysts initiated coverage on Maze Therapeutics, Inc. (NASDAQ:MAZE) with a rating of Buy on October 19, 2026.
Read moreJP Morgan reiterated its Neutral rating on SolarEdge Technologies, Inc. (NASDAQ:SEDG) on October 19, 2026.
Read moreStifel reiterated its Buy rating on Adient plc (NYSE:ADNT) on October 19, 2026.
Read moreJones Trading reiterated its Buy rating on Dynex Capital, Inc. (NYSE:DX) on October 19, 2026.
Read more